SCHEMBL26320508

SCHEMBL26320508

CSCC(=O)c1ccc(C)c(O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPG P10696 6/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
POLB P06746 4/20 0.48
ALPL P05186 4/20 0.48
PLAA Q9Y263 2/20 0.48
ALPI P09923 1/20 0.48
GAA P10253 5/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPT P10636 2/20 0.46
ALOX12 P18054 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HIF1A Q16665 1/20 0.46
NSD2 O96028 1/20 0.43
APEX1 P27695 1/20 0.43
RECQL P46063 1/20 0.43
HDAC6 Q9UBN7 2/20 0.42
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8258568 0.85 ALPG (0.58) ALPGMEN1KMT2APOLBALPL
SCHEMBL10622910 0.79 CYP1A2 (0.44) ALPGMEN1KMT2APOLBALPL
SCHEMBL7049792 0.79 ALDH1A1 (0.50) ALPGMEN1KMT2APOLBALPL
SCHEMBL8680479 0.76 HSD17B3 (0.51) MEN1KMT2AMAPTHTTHDAC6
SCHEMBL11448472 0.76 MCL1 (0.53) ALPGMEN1KMT2APOLBALPL
SCHEMBL10042364 0.75 ALDH1A1 (0.50) ALPGMEN1KMT2APOLBALPL
SCHEMBL11631620 0.75 KMT2A (0.59) MEN1KMT2AGAAHTTSMN1; SMN2
SCHEMBL10418143 0.75 HDAC3 (0.62) MEN1KMT2APOLBKDM4EMAPT
SCHEMBL1758255 0.74 HTT (0.61) POLBMAPTHTTSMN1; SMN2NPC1
SCHEMBL26320526 0.74 ALDH1A1 (0.43) ALPGMEN1KMT2AALPLPLAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230293499-A1 COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO US GOV VETERANS AFFAIRS (US) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230293499-A1 COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO NFKBIA, NCBP1, NFKB1 ALPG 4545/4885MEN1 3170/4885KMT2A 2991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.